These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34763650)

  • 1. Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
    Djuzenova CS; Fischer T; Katzer A; Sisario D; Korsa T; Steussloff G; Sukhorukov VL; Flentje M
    BMC Cancer; 2021 Nov; 21(1):1201. PubMed ID: 34763650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
    Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
    BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.
    Djuzenova CS; Fiedler V; Katzer A; Michel K; Deckert S; Zimmermann H; Sukhorukov VL; Flentje M
    Oncotarget; 2016 Jun; 7(25):38191-38209. PubMed ID: 27224913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.
    Meador JA; Su Y; Ravanat JL; Balajee AS
    Carcinogenesis; 2010 Feb; 31(2):184-91. PubMed ID: 19933707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair.
    Westhoff MA; Kandenwein JA; Karl S; Vellanki SH; Braun V; Eramo A; Antoniadis G; Debatin KM; Fulda S
    Oncogene; 2009 Oct; 28(40):3586-96. PubMed ID: 19633683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
    Memmel S; Sisario D; Zöller C; Fiedler V; Katzer A; Heiden R; Becker N; Eing L; Ferreira FLR; Zimmermann H; Sauer M; Flentje M; Sukhorukov VL; Djuzenova CS
    Oncotarget; 2017 Jul; 8(28):45298-45310. PubMed ID: 28424411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells.
    Pastwa E; Poplawski T; Lewandowska U; Somiari SB; Blasiak J; Somiari RI
    Int J Biochem Cell Biol; 2014 Aug; 53():423-31. PubMed ID: 24953561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor.
    Lankoff A; Bialczyk J; Dziga D; Carmichael WW; Gradzka I; Lisowska H; Kuszewski T; Gozdz S; Piorun I; Wojcik A
    Mutagenesis; 2006 Jan; 21(1):83-90. PubMed ID: 16434448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.
    Azad A; Jackson S; Cullinane C; Natoli A; Neilsen PM; Callen DF; Maira SM; Hackl W; McArthur GA; Solomon B
    Mol Cancer Res; 2011 Dec; 9(12):1696-707. PubMed ID: 22009179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of interferon beta-induced radiosensitization in four out of five human glioblastoma cell lines.
    Schmidberger H; Rave-Fränk M; Lehmann J J; Weiss E; Gerl L; Dettmer N; Glomme S; Hess CF
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1348-57. PubMed ID: 12654447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
    Kuger S; Flentje M; Djuzenova CS
    Radiat Oncol; 2015 Oct; 10():214. PubMed ID: 26498922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA-PKcs and telomerase in brain tumour cells.
    Gurung RL; Lim HK; Venkatesan S; Lee PS; Hande MP
    Mol Cancer; 2014 Oct; 13():232. PubMed ID: 25307264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
    Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
    Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
    Klieber N; Hildebrand LS; Faulhaber E; Symank J; Häck N; Härtl A; Fietkau R; Distel LV
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
    Gustafsson AS; Abramenkovs A; Stenerlöw B
    Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    Ströbele S; Schneider M; Schneele L; Siegelin MD; Nonnenmacher L; Zhou S; Karpel-Massler G; Westhoff MA; Halatsch ME; Debatin KM
    PLoS One; 2015; 10(6):e0131670. PubMed ID: 26121251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2014 Oct; 5(10):e1437. PubMed ID: 25275598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
    BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.